NeuroMatch

by LVIS Corporation  · Based in United States → — Revolutionizing EEG Analysis and Clinical Workflow with AI
Neurology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

NeuroMatch, developed by LVIS Corporation, is a cloud-based, AI-powered software platform designed for the review, monitoring, and analysis of electroencephalogram (EEG) recordings. The platform is built to assist neurologists, epileptologists, and clinical technologists in interpreting complex brain activity by transforming raw EEG signals into structured, multidimensional insights.

The software integrates directly into clinical and diagnostic workflows, offering a suite of automated tools that streamline the review process. Key capabilities of NeuroMatch include:

  • Spike and Seizure Detection: Automated algorithms that mark potential electrographic seizures and spikes in adult EEG recordings to assist clinical assessment.
  • Artifact Reduction: Built-in filtering tools that reduce distracting artifacts from EEG signal data.
  • Source Localization: Advanced 3D and 4D brain network visualizations that map source localization and trends over time.
  • Workflow Automation: Features such as 24-hour trending summaries, longitudinal patient reports, and automated report generation.
  • Remote Collaboration: A secure, browser-based interface that enables multi-physician collaboration and remote access to diagnostic data.

NeuroMatch is designed for use in hospitals, clinics, and epilepsy monitoring units (EMUs). It serves as a clinical decision support tool, relying on the professional judgment of qualified medical practitioners to interpret the processed data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-assisted EEG analysis
  • Artifact reduction
  • Automated reports
  • Longitudinal patient reports
  • 24 hr. Trending Summaries
  • Browser-based access
  • Cloud-based SaaS platform
  • Remote collaboration tools
  • Role-based access controls
  • Seizure detection
  • Spike detection
  • Source localization (NeuroMatch Elite)
  • 3D brain network visualization

Use Cases

  • Streamlining EEG analysis workflow
  • Assisting neurologists in EEG assessment
  • Improving access to neurological care through remote collaboration
  • Diagnosing and treating neurological diseases, particularly epilepsy
  • Reducing time and specialization required for EEG interpretation
  • Tracking patient results over the continuum of care

What Physicians Need to Know

EEG Interpretation AI
NeuroMatch is an AI-enabled platform that leverages deep-learning algorithms for advanced EEG viewing and analysis. It includes features like artifact reduction to improve signal clarity, automated reports, 24-hour trending summaries, and longitudinal patient reports for incremental comparisons between studies. The platform streamlines the analysis of patient signal data and allows neurologists to quickly review and interpret EEG data.
Seizure Detection
NeuroMatch utilizes advanced deep-learning algorithms to automatically identify seizure events and spikes/sharp wave events, which are crucial for diagnosing and managing epilepsy. The system can notify physicians of detected seizures within an hour, enabling rapid intervention. It also offers Seizure Source Localization, allowing clinicians to pinpoint and visualize the origin and evolution of seizure activity on a 3D brain model. These features are FDA-cleared for clinical use.
Brain MRI/CT Analysis
While NeuroMatch is primarily an EEG diagnostic tool, it incorporates 3D brain and MRI templates for mapping source-localized EEG activity, aiding in the spatial understanding of brain electrical signals.
Triage Prioritization Speed
The platform employs AI-supported triage to prioritize EEG studies that require immediate attention, particularly abnormal segments. This can significantly shorten the time to seizure diagnosis and facilitate quicker medication adjustments. For detected seizures, physicians are notified within an hour.
Mobile Notification System
NeuroMatch is a cloud-based, browser-accessible platform, enabling clinicians to review EEG data and reports from any internet-connected device, supporting remote access and collaboration. The system notifies physicians of detected seizures, implying a notification mechanism for rapid intervention.
Physician Tip

Leverage NeuroMatch's AI-driven EEG analysis to significantly reduce manual review time and enhance diagnostic accuracy, especially for seizure and spike detection. Utilize the source localization feature to gain a deeper spatial understanding of brain activity, which can inform targeted treatment plans for epilepsy. The cloud-based access facilitates remote collaboration and review, improving workflow efficiency and patient care accessibility. Remember that while AI assists in detection and triage, clinical judgment remains paramount for final diagnosis and treatment decisions. The automated reports and trending summaries can also aid in longitudinal patient management and tracking treatment efficacy.

NeuroMatch is a cloud-based Software as a Medical Device (SaMD) platform, designed for seamless integration into existing clinical workflows. Its browser-based access eliminates the need for local software installation and supports multi-physician collaboration across different locations. The platform is HIPAA compliant, ensuring secure data storage and access. It is built to support interoperability and scalability within unified hospital and multi-site network EEG programs.

Details

Category Neurology AI
Pricing Contact for pricing
DeploymentCloud-based (SaaS)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

LVIS NeuroMatch Software (K241390) received FDA clearance on November 26, 2024, for the review, monitoring, and analysis of EEG recordings to aid neurologists in assessment, including marking potential seizures or spikes. An updated version, NeuroMatch Elite (K250239), received clearance on May 23, 2025, adding advanced features like seizure and spike source localization.
Integrations
EHR Not specified
Specialties Neurology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate NeuroMatch

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

LVIS Corporation
LVIS Corporation Launches NeuroMatchu00ae: Cloud-Based Platform Revolutionizing EEG Diagnostics
LVIS Corporation launched NeuroMatchu00ae, a cloud-based SaaS platform for EEG diagnostics, in October 2024, aiming to streamline review and enhance physician collaboration in the U.S. market. The platform leverages AI to interpret EEG signals by removing artifacts, facilitating faster and more accurate diagnoses.
2024-10
Medical Product Outsourcing (MPO)
LVIS Corporation Unveils Cloud-Based Platform for EEG Diagnostics
LVIS Corporation introduced NeuroMatch Access, an AI-powered cloud platform to enhance EEG diagnostics by improving clinical workflows and enabling real-time collaboration among neurologists. The platform received U.S. FDA clearance in June 2023 and was launched in South Korea earlier in 2024.
2024-12
Medical Device Network
NeuroMatch EEG diagnostics platform launches in US - Medical Device Network
LVIS Corporation launched its AI-driven NeuroMatch Access platform for EEG data analysis in the US, following 510(k) clearance from the FDA in May 2023. The platform uses AI to interpret EEG signals by removing unwanted artifacts, aiming to speed up and improve the efficiency of clinical workflows.
2024-11
LVIS Corporation
LVIS Corporation Launches NeuroMatch: AI-Powered Seizure and Spike Detection for Enhanced EEG Diagnostics
LVIS Corporation announced a new version of NeuroMatch in February 2025, introducing AI-driven Seizure Detection and Spike Detection features for real-time identification and management of epilepsy-related activity. Both features are FDA-cleared and integrate physician judgment for more reliable clinical decision-making.
2025-02
MLO Online
LVIS Corp launches FDA approved NeuroMatch Elite - MLO Online
LVIS Corp announced the upcoming U.S. release of NeuroMatch Elite, launching with Seizure Source Localization and Spike Source Localization capabilities. This technology offers precise, non-invasive 3D mapping of abnormal brain activity to enhance epilepsy diagnosis and treatment planning.
2025-06
LVIS Corporation
LVIS Corp Set to Revolutionize Epilepsy Diagnosis and Treatment with the Newest Release of NeuroMatch
LVIS Corp announced the U.S. release of NeuroMatch in May 2025, featuring Seizure Source Localization and Spike Source Localization to revolutionize epilepsy care. This advanced tool provides precise 3D mapping of brain activity, enabling more targeted and effective treatment plans.
2025-05
MLO Online
LVIS Corporation launches AI platform that simplifies ambulatory review for effortless clinical workflows | MLO Online
LVIS Corporation enhanced its NeuroMatch platform with full ambulatory EEG capability in August 2025, allowing rapid AI-powered analysis of large data sets and automatic identification of neurological events. This browser-based interface streamlines workflows for healthcare providers, enabling remote monitoring and interpretation of EEG studies.
2025-08
LVIS Corporation
LVIS Corporation Receives Artificial Intelligence Excellence Award for NeuroMatch
LVIS Corporation was recognized by the Business Intelligence Group with a 2026 Artificial Intelligence Excellence Award in the Digital Twin Technology category for its NeuroMatch platform. The award highlights NeuroMatch's ability to create a digital twin of brain activity, transforming raw EEG signals into structured, three-dimensional insights.
2026-04

Videos

Product demos, reviews, and walkthroughs for NeuroMatch.

View all on YouTube

Frequently Asked Questions

NeuroMatch is a cloud-based AI medical software platform designed to streamline EEG review by automating artifact reduction, detecting spikes and seizures, and providing source localization. It offers browser-based access and remote collaboration tools, allowing physicians to review and interpret data more efficiently and collaboratively.
Yes, LVIS NeuroMatch is HIPAA compliant, adhering to required administrative, physical, and technical safeguards for patient data. It employs features such as file integrity scans, multi-factor authentication, a fully managed firewall, and network edge protection to ensure data security.
While NeuroMatch automates key detection tasks and provides rapid assessment, physicians retain full control to review, validate, or refine results in real time. The platform is designed to augment human expertise and enhance diagnostic precision, not to replace the critical judgment and oversight of a neurologist.
While NeuroMatch specializes in AI-driven EEG analysis, other AI tools in healthcare address broader neurological or diagnostic needs, such as Aidoc for emergency radiology or DeepMind Health for diagnostic early warning. For specific EEG analysis, direct alternatives would need to be evaluated based on their AI capabilities for spike and seizure detection and source localization.
NeuroMatch offers advanced pay-per-use options, aiming to provide a scalable and cost-effective solution for modernizing diagnostic capabilities. Specific pricing models, such as subscription tiers or per-study costs, would require direct inquiry with LVIS Corporation.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.